[Influential factors in the quality of prescription in primary care and relation to pharmaceutical expenditure].

Objective: The high pharmaceutical consumption requires establishing improvement measures with the collaboration of all the agents involved. The objective of the study was to analyze the pharmaceutical expenditure generated by prescriptions made by physicians working in a primary care area and assess its relationship with the quality indicators of the prescription.

Methods: The prescriptions of 200 family physicians of the Basque Health Service Araba Countyand dispensed by the community pharmacies between 2009 and 2016 were studied.

The surge in biosimilars: considerations for effective pharmacovigilance and EU regulation.

The development of biosimilars is growing rapidly, especially in Europe. They are a cost-effective alternative to original biological medicines and can help improve patient access to these therapies. The European Medicines Agency (EMA) has been the first to issue scientific guidelines related to regulatory requirements for the approval of biosimilars.

[Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area].

Objective: The proton pump inhibitors (PPI) anti-ulcer drugs are one of the most prescribed pharmacological groups in primary care. The objective of the work was to know the prescription of PPI in a Primary Care Area, the Araba district of the Basque Health Service, to advise family doctors about its correct use, and encourage the prescription of the most efficient PPIs.

Methods: Descriptive study of 200 family doctors PPI prescription at the Araba district of the Basque Health Service.